These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20517807)

  • 1. Lymphocytic colitis under treatment with duloxetine.
    Kusnik B; Stolte M
    Z Gastroenterol; 2010 Jun; 48(6):693-5. PubMed ID: 20517807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Unusual Cause of Chronic Diarrhea.
    Marques S; Carmo J; Bispo M
    Gastroenterology; 2016 Feb; 150(2):326-7. PubMed ID: 26718177
    [No Abstract]   [Full Text] [Related]  

  • 3. Duloxetine-induced lymphocytic colitis.
    Gwillim EC; Bowyer BA
    J Clin Gastroenterol; 2012 Sep; 46(8):717-8. PubMed ID: 22874808
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
    Stovall R; Brahm NC; Crosby KM
    Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic lymphocytic colitis due to duloxetine: Case report and review of the literature.
    Millán-Nohales C; Ordieres-Ortega L; García-Martínez R
    Gastroenterol Hepatol; 2021 Mar; 44(3):222-223. PubMed ID: 33039169
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
    Himmighoffen H; Seifritz E; Boeker H
    Pharmacopsychiatry; 2011 Mar; 44(2):75-6. PubMed ID: 21161885
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors].
    Gross CM; Klöcker M; Jakob T; Klecha D
    Nervenarzt; 2008 Nov; 79(11):1304, 1307-9. PubMed ID: 18958440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.
    Colucci VJ; Berry BD
    Ann Pharmacother; 2008 Jun; 42(6):882-7. PubMed ID: 18445706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin syndrome in an octogenarian after switch from fluoxetine to duloxetine.
    Liu PT; Argento V; Skudlarska B; Blagodatny M
    J Am Geriatr Soc; 2009 Dec; 57(12):2384. PubMed ID: 20122009
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin syndrome induced by duloxetine.
    Hadikusumo B; Ng B
    Aust N Z J Psychiatry; 2009 Jun; 43(6):581-2. PubMed ID: 19452666
    [No Abstract]   [Full Text] [Related]  

  • 11. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.
    Albayrak Y; Ekinci O
    Clin Neuropharmacol; 2011; 34(4):137-8. PubMed ID: 21768799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Tako-tsubo" cardiomyopathy and duloxetine use.
    Rotondi F; Manganelli F; Carbone G; Stanco G
    South Med J; 2011 May; 104(5):345-7. PubMed ID: 21606714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible connection between lymphocytic colitis and sertraline treatment].
    Lindh J
    Lakartidningen; 2012 Jan 11-17; 109(1-2):38. PubMed ID: 22468410
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and tolerability of duloxetine in women with stress urinary incontinence.
    Oelke M; Roovers JP; Michel MC
    BJOG; 2006 May; 113 Suppl 1():22-6. PubMed ID: 16529566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine: withdrawal syndromes.
    Prescrire Int; 2013 Oct; 22(142):243. PubMed ID: 24298592
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of hyponatremia induced by duloxetine.
    Safdieh JE; Rudominer R
    J Clin Psychopharmacol; 2006 Dec; 26(6):675-6. PubMed ID: 17110834
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of apical ballooning cardiomyopathy associated with duloxetine.
    Bergman BR; Reynolds HR; Skolnick AH; Castillo D
    Ann Intern Med; 2008 Aug; 149(3):218-9. PubMed ID: 18678857
    [No Abstract]   [Full Text] [Related]  

  • 18. Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching.
    Peritogiannis V; Antoniou K; Mouka V; Mavreas V; Hyphantis TN
    J Psychopharmacol; 2009 Jul; 23(5):592-6. PubMed ID: 18562441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
    Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
    Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine related hypersexuality: a case report.
    Lai CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):414-5. PubMed ID: 19945494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.